Kings College Team Demonstrates Accuracy of Aria's T21 Test | GenomeWeb

This story was originally published Jan. 27.

In an independent, nested case-control study of 400 pregnant women conducted by researchers from King's College Hospital in the UK, Aria Diagnostics demonstrated that its targeted sequencing-based test to detect trisomy 21 accurately called all cases of trisomy 21 and 98 percent of trisomy 18 cases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.